Acute lung injury occurs as a result of a cascade of cellular events initia
ted by either infectious or noninfectious inflammatory stimuli. An elevated
level of proinflammatory mediators combined with a decreased expression of
anti-inflammatory molecules is a critical component of lung inflammation.
Expression of proinflammatory genes is regulated by transcriptional mechani
sms. Nuclear factor-kappaB (NF-kappaB) is one critical transcription factor
required for maximal expression of many cytokines involved in the pathogen
esis of acute lung injury. Activation and regulation of NF-kappaB are tight
ly controlled by a complicated signaling cascade. In acute lung injury caus
ed by infection of bacteria, Toll-like receptors play a central role in ini
tiating the innate immune system and activating NF-kappaB. Anti-inflammator
y cytokines such as interleukin-10 and interleukin-13 have been shown to su
ppress inflammatory processes through inhibiting NF-kappaB activation. NF-k
appaB can interact with other transcription factors, and these interactions
thereby lead to greater transcriptional selectivity. Modification of trans
cription is likely to be a logical therapeutic target for acute lung injury
.